Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Magnetic Resonance Imaging | 88 | 2023 | 36290 | 1.000 |
Why?
|
Brain Mapping | 29 | 2021 | 6568 | 0.780 |
Why?
|
Schizophrenia | 19 | 2024 | 6915 | 0.730 |
Why?
|
Brain | 45 | 2023 | 26951 | 0.590 |
Why?
|
Acupuncture Analgesia | 6 | 2021 | 63 | 0.580 |
Why?
|
Acupuncture Therapy | 6 | 2023 | 480 | 0.560 |
Why?
|
Diffusion Magnetic Resonance Imaging | 19 | 2021 | 2782 | 0.540 |
Why?
|
Positron-Emission Tomography | 14 | 2022 | 6465 | 0.500 |
Why?
|
Cerebellar Diseases | 4 | 2021 | 219 | 0.480 |
Why?
|
Prefrontal Cortex | 6 | 2021 | 2212 | 0.470 |
Why?
|
Pain Threshold | 7 | 2021 | 603 | 0.440 |
Why?
|
Image Processing, Computer-Assisted | 18 | 2020 | 8950 | 0.430 |
Why?
|
Magnetoencephalography | 7 | 2023 | 634 | 0.420 |
Why?
|
Placebo Effect | 9 | 2021 | 520 | 0.380 |
Why?
|
Prostatic Neoplasms | 12 | 2024 | 11345 | 0.370 |
Why?
|
Neurologic Examination | 4 | 2018 | 916 | 0.370 |
Why?
|
Fear | 5 | 2023 | 1462 | 0.350 |
Why?
|
Neural Pathways | 13 | 2021 | 3040 | 0.350 |
Why?
|
Saccades | 7 | 2014 | 233 | 0.340 |
Why?
|
Psychomotor Performance | 6 | 2024 | 1878 | 0.330 |
Why?
|
Ataxia | 2 | 2022 | 305 | 0.330 |
Why?
|
Oxytocin | 2 | 2024 | 401 | 0.330 |
Why?
|
Pain | 13 | 2021 | 5066 | 0.320 |
Why?
|
Male | 141 | 2024 | 359744 | 0.320 |
Why?
|
Cerebral Cortex | 11 | 2019 | 5761 | 0.310 |
Why?
|
Sleep | 10 | 2024 | 4751 | 0.300 |
Why?
|
Abdominal Neoplasms | 2 | 2021 | 286 | 0.300 |
Why?
|
Memory, Short-Term | 2 | 2011 | 978 | 0.300 |
Why?
|
Electroacupuncture | 4 | 2011 | 66 | 0.300 |
Why?
|
Prostate | 5 | 2019 | 1793 | 0.290 |
Why?
|
Cerebellum | 3 | 2015 | 1496 | 0.280 |
Why?
|
Transcutaneous Electric Nerve Stimulation | 2 | 2021 | 170 | 0.280 |
Why?
|
Humans | 177 | 2024 | 760621 | 0.270 |
Why?
|
Acupuncture Points | 5 | 2013 | 111 | 0.270 |
Why?
|
Adult | 98 | 2024 | 219994 | 0.260 |
Why?
|
Nerve Fibers, Myelinated | 5 | 2018 | 952 | 0.260 |
Why?
|
Female | 125 | 2024 | 391270 | 0.260 |
Why?
|
Diffusion Tensor Imaging | 11 | 2022 | 2385 | 0.260 |
Why?
|
Vagus Nerve Stimulation | 2 | 2021 | 224 | 0.260 |
Why?
|
Brain Infarction | 4 | 2011 | 292 | 0.250 |
Why?
|
Administration, Intranasal | 2 | 2024 | 471 | 0.250 |
Why?
|
Movement Disorders | 1 | 2009 | 459 | 0.250 |
Why?
|
Disability Evaluation | 2 | 2009 | 1826 | 0.250 |
Why?
|
Middle Aged | 86 | 2022 | 220352 | 0.250 |
Why?
|
Fluorodeoxyglucose F18 | 9 | 2022 | 2007 | 0.240 |
Why?
|
Hyperalgesia | 3 | 2021 | 530 | 0.240 |
Why?
|
Functional Laterality | 8 | 2019 | 2253 | 0.240 |
Why?
|
Algorithms | 10 | 2019 | 13981 | 0.240 |
Why?
|
Stroke | 10 | 2017 | 9962 | 0.240 |
Why?
|
Magnetic Resonance Imaging, Interventional | 2 | 2017 | 187 | 0.230 |
Why?
|
Gadolinium DTPA | 6 | 2019 | 823 | 0.220 |
Why?
|
Image Interpretation, Computer-Assisted | 11 | 2016 | 3340 | 0.220 |
Why?
|
Huntington Disease | 4 | 2018 | 1141 | 0.220 |
Why?
|
Analysis of Variance | 8 | 2021 | 6238 | 0.220 |
Why?
|
Gyrus Cinguli | 8 | 2019 | 1114 | 0.210 |
Why?
|
Somatosensory Cortex | 4 | 2011 | 511 | 0.210 |
Why?
|
Frontal Lobe | 6 | 2015 | 1420 | 0.210 |
Why?
|
Cognition Disorders | 4 | 2022 | 3976 | 0.210 |
Why?
|
Young Adult | 35 | 2024 | 58741 | 0.200 |
Why?
|
Neck Pain | 1 | 2023 | 186 | 0.200 |
Why?
|
Contrast Media | 11 | 2019 | 5305 | 0.200 |
Why?
|
Acoustic Stimulation | 2 | 2023 | 1232 | 0.200 |
Why?
|
Mental Recall | 3 | 2023 | 1206 | 0.200 |
Why?
|
Pain Perception | 2 | 2014 | 196 | 0.190 |
Why?
|
Anisotropy | 7 | 2022 | 1278 | 0.190 |
Why?
|
Severity of Illness Index | 7 | 2018 | 15840 | 0.190 |
Why?
|
Nerve Net | 7 | 2014 | 2261 | 0.190 |
Why?
|
Hippocampus | 6 | 2024 | 3738 | 0.190 |
Why?
|
Pain Measurement | 11 | 2015 | 3528 | 0.190 |
Why?
|
Inositol | 1 | 2021 | 215 | 0.180 |
Why?
|
Pressure Ulcer | 1 | 2022 | 156 | 0.180 |
Why?
|
Language | 2 | 2021 | 1533 | 0.180 |
Why?
|
Evoked Potentials | 3 | 2014 | 1036 | 0.180 |
Why?
|
Extinction, Psychological | 2 | 2023 | 371 | 0.180 |
Why?
|
Consumer Product Safety | 1 | 2020 | 123 | 0.170 |
Why?
|
Evoked Potentials, Auditory | 1 | 2023 | 529 | 0.170 |
Why?
|
Reproducibility of Results | 19 | 2019 | 20080 | 0.170 |
Why?
|
Aged | 53 | 2021 | 169152 | 0.170 |
Why?
|
Rest | 5 | 2016 | 914 | 0.170 |
Why?
|
Carcinoma, Ductal, Breast | 2 | 2017 | 1096 | 0.170 |
Why?
|
Cognition | 9 | 2022 | 6957 | 0.170 |
Why?
|
Polysomnography | 4 | 2019 | 1825 | 0.170 |
Why?
|
Conditioning, Classical | 2 | 2019 | 364 | 0.160 |
Why?
|
Sensitivity and Specificity | 14 | 2022 | 14660 | 0.160 |
Why?
|
Brain Ischemia | 5 | 2017 | 3127 | 0.160 |
Why?
|
Cerebral Infarction | 5 | 2008 | 982 | 0.160 |
Why?
|
Vascular System Injuries | 1 | 2022 | 247 | 0.160 |
Why?
|
Generalization, Response | 1 | 2018 | 8 | 0.160 |
Why?
|
Whole Body Imaging | 2 | 2020 | 278 | 0.160 |
Why?
|
Simian Acquired Immunodeficiency Syndrome | 2 | 2018 | 538 | 0.160 |
Why?
|
Corneal Ulcer | 1 | 2019 | 128 | 0.160 |
Why?
|
Verbal Behavior | 1 | 2020 | 335 | 0.160 |
Why?
|
Psychotic Disorders | 2 | 2024 | 3193 | 0.160 |
Why?
|
Acupuncture | 2 | 2010 | 90 | 0.150 |
Why?
|
Tomography, X-Ray Computed | 9 | 2021 | 20509 | 0.150 |
Why?
|
Galvanic Skin Response | 2 | 2018 | 348 | 0.150 |
Why?
|
Qi | 2 | 2007 | 15 | 0.150 |
Why?
|
Social Perception | 2 | 2016 | 431 | 0.150 |
Why?
|
Auditory Perception | 1 | 2023 | 580 | 0.150 |
Why?
|
Brain Neoplasms | 4 | 2021 | 8986 | 0.150 |
Why?
|
Magnetic Resonance Spectroscopy | 3 | 2021 | 3765 | 0.150 |
Why?
|
Depressive Disorder, Major | 4 | 2021 | 4744 | 0.150 |
Why?
|
Pancreatic Neoplasms | 3 | 2022 | 5351 | 0.150 |
Why?
|
Neoplasm Staging | 10 | 2019 | 11152 | 0.150 |
Why?
|
Motor Skills | 4 | 2024 | 520 | 0.150 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2021 | 632 | 0.150 |
Why?
|
Respiratory-Gated Imaging Techniques | 1 | 2018 | 75 | 0.150 |
Why?
|
Myelin Sheath | 2 | 2021 | 652 | 0.150 |
Why?
|
Reaction Time | 9 | 2013 | 2075 | 0.150 |
Why?
|
Blood Coagulation Disorders | 1 | 2021 | 349 | 0.150 |
Why?
|
Infarction, Middle Cerebral Artery | 3 | 2016 | 485 | 0.140 |
Why?
|
Retrospective Studies | 30 | 2022 | 80372 | 0.140 |
Why?
|
Pattern Recognition, Automated | 2 | 2016 | 994 | 0.140 |
Why?
|
Androgen Antagonists | 2 | 2024 | 1442 | 0.140 |
Why?
|
Oxygen | 5 | 2017 | 4193 | 0.140 |
Why?
|
Sex Characteristics | 3 | 2021 | 2629 | 0.140 |
Why?
|
Placental Insufficiency | 1 | 2017 | 50 | 0.140 |
Why?
|
Electroencephalography | 7 | 2023 | 6189 | 0.140 |
Why?
|
Cerebral Arterial Diseases | 1 | 2017 | 82 | 0.140 |
Why?
|
Eye Infections, Bacterial | 1 | 2019 | 239 | 0.140 |
Why?
|
Laryngeal Diseases | 1 | 2020 | 244 | 0.140 |
Why?
|
Intubation, Intratracheal | 2 | 2022 | 1328 | 0.140 |
Why?
|
Sensation | 2 | 2009 | 331 | 0.140 |
Why?
|
Analgesia | 1 | 2021 | 459 | 0.140 |
Why?
|
Foreign Bodies | 1 | 2020 | 397 | 0.130 |
Why?
|
Corneal Diseases | 1 | 2022 | 536 | 0.130 |
Why?
|
Voice Disorders | 1 | 2020 | 286 | 0.130 |
Why?
|
Government Regulation | 1 | 2020 | 525 | 0.130 |
Why?
|
Caffeine | 1 | 2021 | 702 | 0.130 |
Why?
|
Ear Auricle | 1 | 2016 | 31 | 0.130 |
Why?
|
Mitotic Index | 1 | 2016 | 161 | 0.130 |
Why?
|
Radiopharmaceuticals | 7 | 2022 | 2634 | 0.130 |
Why?
|
Likelihood Functions | 1 | 1999 | 987 | 0.130 |
Why?
|
Cross-Over Studies | 6 | 2021 | 2061 | 0.130 |
Why?
|
Osteoarthritis, Knee | 2 | 2016 | 1234 | 0.130 |
Why?
|
Hot Temperature | 5 | 2015 | 1435 | 0.130 |
Why?
|
Peritoneal Neoplasms | 1 | 2022 | 707 | 0.130 |
Why?
|
Colorectal Neoplasms | 3 | 2021 | 6853 | 0.120 |
Why?
|
Aged, 80 and over | 24 | 2020 | 58995 | 0.120 |
Why?
|
Bone Neoplasms | 2 | 2019 | 2532 | 0.120 |
Why?
|
Neurofibromatosis 1 | 1 | 2020 | 560 | 0.120 |
Why?
|
Pilot Projects | 7 | 2024 | 8555 | 0.120 |
Why?
|
3-Oxo-5-alpha-Steroid 4-Dehydrogenase | 1 | 2015 | 70 | 0.120 |
Why?
|
Nerve Degeneration | 2 | 2018 | 748 | 0.120 |
Why?
|
Models, Theoretical | 2 | 2018 | 3562 | 0.120 |
Why?
|
Obesity | 3 | 2024 | 12922 | 0.120 |
Why?
|
Synovitis | 1 | 2016 | 215 | 0.120 |
Why?
|
Temporomandibular Joint | 1 | 2016 | 196 | 0.120 |
Why?
|
Bipolar Disorder | 1 | 2011 | 5078 | 0.120 |
Why?
|
Radiology Information Systems | 1 | 2019 | 528 | 0.120 |
Why?
|
Video Recording | 1 | 2019 | 955 | 0.110 |
Why?
|
Cholangiocarcinoma | 1 | 2019 | 550 | 0.110 |
Why?
|
Bile Duct Neoplasms | 1 | 2019 | 602 | 0.110 |
Why?
|
Executive Function | 3 | 2018 | 1374 | 0.110 |
Why?
|
Methylenetetrahydrofolate Reductase (NADPH2) | 2 | 2014 | 275 | 0.110 |
Why?
|
Axons | 2 | 2021 | 1673 | 0.110 |
Why?
|
Neuropsychological Tests | 8 | 2018 | 7021 | 0.110 |
Why?
|
Cerebrovascular Circulation | 3 | 2015 | 2733 | 0.110 |
Why?
|
Adolescent | 22 | 2024 | 87810 | 0.110 |
Why?
|
Predictive Value of Tests | 11 | 2021 | 15289 | 0.110 |
Why?
|
Prospective Studies | 17 | 2024 | 54303 | 0.110 |
Why?
|
Motion Sickness | 1 | 2013 | 32 | 0.110 |
Why?
|
Simian immunodeficiency virus | 1 | 2018 | 805 | 0.110 |
Why?
|
Parietal Lobe | 5 | 2015 | 850 | 0.110 |
Why?
|
Postpartum Period | 1 | 2020 | 1167 | 0.110 |
Why?
|
Thalamus | 1 | 2019 | 1041 | 0.100 |
Why?
|
Models, Neurological | 2 | 2012 | 1758 | 0.100 |
Why?
|
Neoadjuvant Therapy | 2 | 2024 | 2821 | 0.100 |
Why?
|
Infectious Disease Transmission, Vertical | 1 | 2020 | 1348 | 0.100 |
Why?
|
Double-Blind Method | 6 | 2024 | 12427 | 0.100 |
Why?
|
HIV | 1 | 2020 | 1579 | 0.100 |
Why?
|
Glaucoma | 1 | 2022 | 1182 | 0.100 |
Why?
|
Cryosurgery | 1 | 2017 | 475 | 0.100 |
Why?
|
Image Enhancement | 4 | 2016 | 2881 | 0.100 |
Why?
|
Connective Tissue | 1 | 2014 | 416 | 0.100 |
Why?
|
Spinocerebellar Ataxias | 1 | 2013 | 104 | 0.100 |
Why?
|
Catechol O-Methyltransferase | 1 | 2014 | 251 | 0.100 |
Why?
|
Panic Disorder | 1 | 2015 | 613 | 0.100 |
Why?
|
Regression Analysis | 7 | 2020 | 6360 | 0.100 |
Why?
|
Acupressure | 1 | 2011 | 16 | 0.100 |
Why?
|
Neurosurgical Procedures | 2 | 2020 | 2056 | 0.100 |
Why?
|
Microvessels | 1 | 2016 | 572 | 0.100 |
Why?
|
Child of Impaired Parents | 1 | 2015 | 459 | 0.100 |
Why?
|
Rectal Neoplasms | 1 | 2020 | 1152 | 0.100 |
Why?
|
Sleep Stages | 2 | 2020 | 691 | 0.100 |
Why?
|
Angiogenesis Inhibitors | 1 | 2021 | 2049 | 0.100 |
Why?
|
Ischemic Attack, Transient | 2 | 2008 | 901 | 0.090 |
Why?
|
Cardiac Resynchronization Therapy | 1 | 2017 | 553 | 0.090 |
Why?
|
Hormone Antagonists | 1 | 2011 | 108 | 0.090 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2022 | 1724 | 0.090 |
Why?
|
Prostatic Hyperplasia | 1 | 2015 | 530 | 0.090 |
Why?
|
Self Report | 2 | 2020 | 3711 | 0.090 |
Why?
|
Evoked Potentials, Somatosensory | 1 | 2012 | 246 | 0.090 |
Why?
|
Learning | 2 | 2014 | 1739 | 0.090 |
Why?
|
Orbit | 1 | 2014 | 446 | 0.090 |
Why?
|
Preoperative Care | 1 | 2020 | 2256 | 0.090 |
Why?
|
Mifepristone | 1 | 2011 | 150 | 0.090 |
Why?
|
Mastectomy, Segmental | 1 | 2016 | 972 | 0.090 |
Why?
|
Pyramidal Tracts | 2 | 2009 | 250 | 0.090 |
Why?
|
Microcirculation | 1 | 2015 | 1278 | 0.090 |
Why?
|
Paresis | 1 | 2011 | 177 | 0.090 |
Why?
|
Personality | 1 | 2014 | 552 | 0.090 |
Why?
|
Brain Injuries | 1 | 2022 | 2044 | 0.090 |
Why?
|
Fibromyalgia | 1 | 2015 | 401 | 0.090 |
Why?
|
Neoplasm Invasiveness | 1 | 2018 | 3618 | 0.090 |
Why?
|
Radiography, Interventional | 1 | 2017 | 1114 | 0.090 |
Why?
|
Leukoaraiosis | 1 | 2011 | 116 | 0.090 |
Why?
|
Longitudinal Studies | 8 | 2021 | 14495 | 0.090 |
Why?
|
Amygdala | 2 | 2009 | 1351 | 0.090 |
Why?
|
Intention | 1 | 2013 | 345 | 0.090 |
Why?
|
Cues | 2 | 2013 | 867 | 0.090 |
Why?
|
Emergency Service, Hospital | 2 | 2020 | 7818 | 0.090 |
Why?
|
Spectroscopy, Near-Infrared | 1 | 2015 | 741 | 0.090 |
Why?
|
Nausea | 1 | 2013 | 678 | 0.090 |
Why?
|
Seasonal Affective Disorder | 1 | 2009 | 49 | 0.080 |
Why?
|
Microscopy, Confocal | 1 | 2016 | 1972 | 0.080 |
Why?
|
Propranolol | 1 | 2011 | 489 | 0.080 |
Why?
|
RNA, Viral | 1 | 2018 | 2838 | 0.080 |
Why?
|
Neuroendocrine Tumors | 1 | 2016 | 650 | 0.080 |
Why?
|
Linear Models | 3 | 2020 | 5877 | 0.080 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 2018 | 2197 | 0.080 |
Why?
|
Prostatectomy | 4 | 2019 | 1956 | 0.080 |
Why?
|
Reperfusion Injury | 1 | 2016 | 1023 | 0.080 |
Why?
|
Patient Acceptance of Health Care | 2 | 2020 | 3164 | 0.080 |
Why?
|
Neuroglia | 1 | 2015 | 944 | 0.080 |
Why?
|
Time Factors | 13 | 2018 | 40165 | 0.080 |
Why?
|
Anxiety | 4 | 2020 | 4538 | 0.080 |
Why?
|
Infant Behavior | 1 | 2010 | 154 | 0.080 |
Why?
|
Breast Neoplasms | 4 | 2017 | 21025 | 0.080 |
Why?
|
Photic Stimulation | 5 | 2015 | 1967 | 0.080 |
Why?
|
Single-Blind Method | 3 | 2021 | 1578 | 0.080 |
Why?
|
Artifacts | 2 | 2015 | 1898 | 0.080 |
Why?
|
Genetic Association Studies | 2 | 2020 | 2717 | 0.080 |
Why?
|
Cost of Illness | 1 | 2018 | 1940 | 0.080 |
Why?
|
Anti-Retroviral Agents | 1 | 2018 | 1779 | 0.080 |
Why?
|
Carbonated Beverages | 1 | 2009 | 209 | 0.080 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2020 | 2125 | 0.070 |
Why?
|
Physical Therapy Modalities | 1 | 2011 | 536 | 0.070 |
Why?
|
Standard of Care | 2 | 2022 | 552 | 0.070 |
Why?
|
Lung Neoplasms | 5 | 2021 | 13262 | 0.070 |
Why?
|
Meditation | 1 | 2010 | 251 | 0.070 |
Why?
|
Arrhythmias, Cardiac | 1 | 2017 | 2255 | 0.070 |
Why?
|
Organ Size | 3 | 2017 | 2254 | 0.070 |
Why?
|
Temperament | 1 | 2010 | 295 | 0.070 |
Why?
|
Nerve Fibers, Unmyelinated | 1 | 2007 | 97 | 0.070 |
Why?
|
Memory | 3 | 2024 | 2179 | 0.070 |
Why?
|
Laboratories | 2 | 2003 | 462 | 0.070 |
Why?
|
Corpus Callosum | 2 | 2009 | 749 | 0.070 |
Why?
|
Coma | 1 | 2011 | 487 | 0.070 |
Why?
|
Motor Cortex | 1 | 2014 | 995 | 0.070 |
Why?
|
Hospital Mortality | 2 | 2017 | 5425 | 0.070 |
Why?
|
Glioblastoma | 1 | 2021 | 3484 | 0.070 |
Why?
|
Ultrasonography | 2 | 2017 | 5961 | 0.070 |
Why?
|
Surgery, Computer-Assisted | 1 | 2014 | 1008 | 0.070 |
Why?
|
Neuralgia | 1 | 2012 | 600 | 0.070 |
Why?
|
Prognosis | 12 | 2017 | 29658 | 0.070 |
Why?
|
Basal Ganglia | 2 | 2006 | 552 | 0.070 |
Why?
|
Rectum | 1 | 2010 | 895 | 0.060 |
Why?
|
Aging | 4 | 2021 | 8651 | 0.060 |
Why?
|
Dominance, Cerebral | 1 | 2007 | 622 | 0.060 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2018 | 2276 | 0.060 |
Why?
|
Histones | 1 | 2016 | 2583 | 0.060 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2011 | 1259 | 0.060 |
Why?
|
Vision, Ocular | 1 | 2009 | 454 | 0.060 |
Why?
|
Orientation | 1 | 2007 | 321 | 0.060 |
Why?
|
Biopsy | 2 | 2015 | 6771 | 0.060 |
Why?
|
Neuronal Plasticity | 2 | 2011 | 1430 | 0.060 |
Why?
|
Macaca mulatta | 2 | 2018 | 2316 | 0.060 |
Why?
|
Chi-Square Distribution | 1 | 2011 | 3465 | 0.060 |
Why?
|
Stem Cell Transplantation | 2 | 2004 | 1599 | 0.060 |
Why?
|
Organometallic Compounds | 1 | 2009 | 662 | 0.060 |
Why?
|
Choline O-Acetyltransferase | 1 | 2005 | 155 | 0.060 |
Why?
|
Irritable Bowel Syndrome | 1 | 2010 | 453 | 0.060 |
Why?
|
Anticoagulants | 1 | 2021 | 4897 | 0.060 |
Why?
|
Psychiatric Status Rating Scales | 4 | 2018 | 6015 | 0.060 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 4 | 2004 | 5251 | 0.060 |
Why?
|
Energy Metabolism | 3 | 2024 | 2869 | 0.060 |
Why?
|
Dietary Carbohydrates | 1 | 2009 | 892 | 0.060 |
Why?
|
Needles | 1 | 2007 | 451 | 0.060 |
Why?
|
Food | 1 | 2009 | 771 | 0.060 |
Why?
|
Models, Biological | 3 | 2016 | 9467 | 0.060 |
Why?
|
Motor Activity | 1 | 2014 | 2687 | 0.060 |
Why?
|
Ki-67 Antigen | 2 | 2017 | 631 | 0.060 |
Why?
|
Reference Values | 4 | 2021 | 4925 | 0.060 |
Why?
|
Oxygen Inhalation Therapy | 1 | 2007 | 404 | 0.060 |
Why?
|
Child | 11 | 2023 | 79806 | 0.060 |
Why?
|
Gait | 1 | 2009 | 812 | 0.060 |
Why?
|
Peripheral Nerves | 1 | 2007 | 475 | 0.060 |
Why?
|
Brain Concussion | 1 | 2015 | 1394 | 0.060 |
Why?
|
Catheter Ablation | 1 | 2017 | 2758 | 0.060 |
Why?
|
Case-Control Studies | 8 | 2020 | 22053 | 0.060 |
Why?
|
Placebos | 3 | 2019 | 1668 | 0.060 |
Why?
|
Anti-HIV Agents | 1 | 2020 | 4491 | 0.060 |
Why?
|
Emotions | 2 | 2019 | 2734 | 0.060 |
Why?
|
Psychophysics | 3 | 2012 | 289 | 0.060 |
Why?
|
Acute Kidney Injury | 1 | 2016 | 1941 | 0.060 |
Why?
|
Oligopeptides | 1 | 2009 | 1187 | 0.050 |
Why?
|
Age Factors | 5 | 2015 | 18416 | 0.050 |
Why?
|
Carpal Tunnel Syndrome | 1 | 2007 | 303 | 0.050 |
Why?
|
Statistics as Topic | 3 | 2016 | 2362 | 0.050 |
Why?
|
Adenocarcinoma | 1 | 2021 | 6315 | 0.050 |
Why?
|
Observer Variation | 4 | 2016 | 2601 | 0.050 |
Why?
|
Multicenter Studies as Topic | 1 | 2008 | 1722 | 0.050 |
Why?
|
Fingers | 3 | 2014 | 506 | 0.050 |
Why?
|
Motion | 2 | 2018 | 779 | 0.050 |
Why?
|
Sympathetic Nervous System | 1 | 2006 | 520 | 0.050 |
Why?
|
Schizophrenic Psychology | 2 | 2011 | 1646 | 0.050 |
Why?
|
Visual Perception | 2 | 2018 | 1374 | 0.050 |
Why?
|
Crohn Disease | 1 | 2015 | 2275 | 0.050 |
Why?
|
Coronary Stenosis | 1 | 2009 | 820 | 0.050 |
Why?
|
Treatment Outcome | 12 | 2022 | 65017 | 0.050 |
Why?
|
Perception | 1 | 2009 | 1195 | 0.050 |
Why?
|
Anger | 1 | 2005 | 401 | 0.050 |
Why?
|
Occipital Lobe | 1 | 2004 | 373 | 0.050 |
Why?
|
Sleep Disorders, Circadian Rhythm | 1 | 2005 | 196 | 0.050 |
Why?
|
Follow-Up Studies | 7 | 2019 | 39261 | 0.050 |
Why?
|
Cohort Studies | 8 | 2021 | 41335 | 0.050 |
Why?
|
Problem Solving | 1 | 2004 | 440 | 0.050 |
Why?
|
Tumor Burden | 2 | 2020 | 1895 | 0.050 |
Why?
|
Cadmium | 1 | 2023 | 215 | 0.050 |
Why?
|
Amnesia | 1 | 2024 | 255 | 0.050 |
Why?
|
Culture | 1 | 2006 | 622 | 0.050 |
Why?
|
Weight Loss | 2 | 2024 | 2686 | 0.050 |
Why?
|
Acute Disease | 4 | 2016 | 7269 | 0.050 |
Why?
|
Liver Neoplasms | 1 | 2017 | 4319 | 0.050 |
Why?
|
Hypothalamus | 1 | 2007 | 998 | 0.050 |
Why?
|
Colombia | 1 | 2022 | 276 | 0.050 |
Why?
|
Attention | 2 | 2016 | 2387 | 0.050 |
Why?
|
Endocarditis | 1 | 2005 | 351 | 0.050 |
Why?
|
Pattern Recognition, Visual | 1 | 2007 | 810 | 0.050 |
Why?
|
Anti-Bacterial Agents | 1 | 2019 | 7408 | 0.050 |
Why?
|
Arterial Occlusive Diseases | 1 | 2005 | 752 | 0.050 |
Why?
|
Visual Cortex | 1 | 2009 | 1089 | 0.050 |
Why?
|
Neurons | 2 | 2018 | 9426 | 0.050 |
Why?
|
Recovery of Function | 1 | 2011 | 2985 | 0.050 |
Why?
|
Genome, Human | 1 | 2014 | 4417 | 0.050 |
Why?
|
Troponin T | 1 | 2006 | 774 | 0.050 |
Why?
|
Atherosclerosis | 1 | 2017 | 3517 | 0.050 |
Why?
|
Genotype | 4 | 2020 | 12960 | 0.050 |
Why?
|
Heart Arrest | 1 | 2011 | 1506 | 0.050 |
Why?
|
Interneurons | 1 | 2005 | 591 | 0.050 |
Why?
|
Collagen | 1 | 2009 | 2636 | 0.050 |
Why?
|
Kidney | 1 | 2016 | 7064 | 0.040 |
Why?
|
Imaging, Three-Dimensional | 3 | 2010 | 4048 | 0.040 |
Why?
|
Research Design | 2 | 2024 | 6180 | 0.040 |
Why?
|
Thoracic Surgical Procedures | 1 | 2004 | 348 | 0.040 |
Why?
|
Equipment Failure | 1 | 2022 | 577 | 0.040 |
Why?
|
Eye Evisceration | 1 | 2019 | 22 | 0.040 |
Why?
|
Nerve Tissue Proteins | 1 | 2013 | 4407 | 0.040 |
Why?
|
Surgical Instruments | 1 | 2022 | 385 | 0.040 |
Why?
|
Prostate-Specific Antigen | 2 | 2024 | 2529 | 0.040 |
Why?
|
Activities of Daily Living | 1 | 2009 | 2417 | 0.040 |
Why?
|
Eye Enucleation | 1 | 2019 | 128 | 0.040 |
Why?
|
Corneal Perforation | 1 | 2019 | 29 | 0.040 |
Why?
|
Neurofibroma | 1 | 2020 | 94 | 0.040 |
Why?
|
Cerebral Angiography | 1 | 2005 | 1274 | 0.040 |
Why?
|
Phenotype | 5 | 2020 | 16546 | 0.040 |
Why?
|
Ascorbic Acid | 1 | 2003 | 655 | 0.040 |
Why?
|
Early Diagnosis | 3 | 2011 | 1180 | 0.040 |
Why?
|
Atrial Fibrillation | 1 | 2018 | 5209 | 0.040 |
Why?
|
Tissue Plasminogen Activator | 1 | 2005 | 1190 | 0.040 |
Why?
|
Japan | 1 | 2023 | 1369 | 0.040 |
Why?
|
Melatonin | 1 | 2005 | 668 | 0.040 |
Why?
|
Glioma | 1 | 2014 | 3420 | 0.040 |
Why?
|
Keratoplasty, Penetrating | 1 | 2019 | 144 | 0.040 |
Why?
|
Vagus Nerve | 1 | 2021 | 458 | 0.040 |
Why?
|
Citalopram | 1 | 2021 | 402 | 0.040 |
Why?
|
Transplantation, Homologous | 2 | 2004 | 4810 | 0.040 |
Why?
|
Survival Rate | 4 | 2021 | 12808 | 0.040 |
Why?
|
Disease Progression | 5 | 2017 | 13502 | 0.040 |
Why?
|
Liposomes | 1 | 2022 | 777 | 0.040 |
Why?
|
Limbic System | 1 | 2021 | 419 | 0.040 |
Why?
|
Phonation | 1 | 2020 | 220 | 0.040 |
Why?
|
Hospitalization | 1 | 2018 | 10790 | 0.040 |
Why?
|
Face | 1 | 2004 | 1017 | 0.040 |
Why?
|
Cerebral Hemorrhage | 2 | 2009 | 2660 | 0.040 |
Why?
|
Airway Management | 1 | 2021 | 310 | 0.040 |
Why?
|
Prosthesis Implantation | 1 | 2022 | 594 | 0.040 |
Why?
|
Intensive Care Units | 2 | 2021 | 3736 | 0.040 |
Why?
|
International Cooperation | 1 | 2024 | 1433 | 0.040 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2021 | 9276 | 0.040 |
Why?
|
United States | 6 | 2022 | 72461 | 0.040 |
Why?
|
Minocycline | 1 | 2018 | 168 | 0.040 |
Why?
|
Endophthalmitis | 1 | 2019 | 257 | 0.040 |
Why?
|
Biological Specimen Banks | 1 | 2022 | 783 | 0.030 |
Why?
|
Myocardium | 2 | 2009 | 4700 | 0.030 |
Why?
|
Brain Diseases | 1 | 2006 | 1540 | 0.030 |
Why?
|
Incidence | 4 | 2020 | 21392 | 0.030 |
Why?
|
Animals | 10 | 2022 | 167963 | 0.030 |
Why?
|
Temporal Lobe | 1 | 2004 | 1688 | 0.030 |
Why?
|
Random Allocation | 1 | 2021 | 2394 | 0.030 |
Why?
|
Bone Marrow Transplantation | 1 | 2004 | 2693 | 0.030 |
Why?
|
Voice | 1 | 2020 | 267 | 0.030 |
Why?
|
Hematoxylin | 1 | 2016 | 60 | 0.030 |
Why?
|
Eosine Yellowish-(YS) | 1 | 2016 | 69 | 0.030 |
Why?
|
Energy Intake | 1 | 2024 | 2129 | 0.030 |
Why?
|
Androgens | 1 | 2024 | 1291 | 0.030 |
Why?
|
Corpus Striatum | 2 | 2014 | 1233 | 0.030 |
Why?
|
Demography | 1 | 2021 | 1650 | 0.030 |
Why?
|
Oxygen Consumption | 2 | 2015 | 1843 | 0.030 |
Why?
|
Cross-Sectional Studies | 3 | 2022 | 25942 | 0.030 |
Why?
|
Biometry | 1 | 1999 | 559 | 0.030 |
Why?
|
Disease Models, Animal | 4 | 2018 | 18137 | 0.030 |
Why?
|
Neoplasms, Second Primary | 1 | 2003 | 1056 | 0.030 |
Why?
|
Verbal Learning | 1 | 2018 | 462 | 0.030 |
Why?
|
Emotional Intelligence | 1 | 2016 | 135 | 0.030 |
Why?
|
Fibrinolytic Agents | 1 | 2005 | 2167 | 0.030 |
Why?
|
Prostheses and Implants | 1 | 2022 | 1273 | 0.030 |
Why?
|
Treatment Failure | 1 | 2021 | 2648 | 0.030 |
Why?
|
Sleep Initiation and Maintenance Disorders | 1 | 2005 | 1079 | 0.030 |
Why?
|
Vocal Cords | 1 | 2020 | 523 | 0.030 |
Why?
|
Physical Stimulation | 2 | 2008 | 518 | 0.030 |
Why?
|
Hyperoxia | 1 | 2017 | 250 | 0.030 |
Why?
|
Lymphatic Metastasis | 2 | 2018 | 2943 | 0.030 |
Why?
|
Microbubbles | 1 | 2016 | 128 | 0.030 |
Why?
|
Proportional Hazards Models | 3 | 2016 | 12531 | 0.030 |
Why?
|
Autistic Disorder | 1 | 2004 | 1216 | 0.030 |
Why?
|
Body Composition | 1 | 2024 | 2419 | 0.030 |
Why?
|
Self Administration | 1 | 2016 | 390 | 0.030 |
Why?
|
Cornea | 1 | 2022 | 1326 | 0.030 |
Why?
|
Cluster Analysis | 1 | 2021 | 2698 | 0.030 |
Why?
|
Skin | 2 | 2023 | 4466 | 0.030 |
Why?
|
Ependyma | 1 | 2014 | 56 | 0.030 |
Why?
|
Kaplan-Meier Estimate | 2 | 2016 | 6544 | 0.030 |
Why?
|
Head Injuries, Closed | 1 | 2015 | 133 | 0.030 |
Why?
|
Personality Tests | 1 | 2014 | 81 | 0.030 |
Why?
|
South Africa | 1 | 2020 | 1821 | 0.030 |
Why?
|
Blood Gas Analysis | 1 | 2015 | 379 | 0.030 |
Why?
|
Intensive Care Units, Pediatric | 1 | 2021 | 1014 | 0.030 |
Why?
|
United States Food and Drug Administration | 1 | 2022 | 1677 | 0.030 |
Why?
|
Cardiomyopathies | 1 | 2006 | 1952 | 0.030 |
Why?
|
Risk Factors | 5 | 2022 | 74359 | 0.030 |
Why?
|
ROC Curve | 2 | 2016 | 3568 | 0.030 |
Why?
|
Radiotherapy, Adjuvant | 3 | 2004 | 1791 | 0.030 |
Why?
|
Child, Preschool | 5 | 2020 | 42063 | 0.030 |
Why?
|
Receptors, Dopamine D4 | 1 | 2014 | 170 | 0.030 |
Why?
|
Causality | 2 | 2011 | 1242 | 0.030 |
Why?
|
Macaca fascicularis | 1 | 2015 | 900 | 0.030 |
Why?
|
Arteries | 1 | 2018 | 1126 | 0.030 |
Why?
|
Maze Learning | 1 | 2015 | 477 | 0.030 |
Why?
|
Coloring Agents | 1 | 2016 | 562 | 0.030 |
Why?
|
Length of Stay | 2 | 2017 | 6479 | 0.030 |
Why?
|
Computer Simulation | 3 | 2015 | 6218 | 0.030 |
Why?
|
Intranuclear Inclusion Bodies | 1 | 2013 | 34 | 0.030 |
Why?
|
Microbial Sensitivity Tests | 1 | 2019 | 1949 | 0.030 |
Why?
|
Prevalence | 2 | 2022 | 15687 | 0.030 |
Why?
|
HIV Infections | 1 | 2020 | 17165 | 0.030 |
Why?
|
Perineum | 1 | 2014 | 208 | 0.030 |
Why?
|
Cystectomy | 1 | 2018 | 697 | 0.030 |
Why?
|
Confidence Intervals | 1 | 1999 | 2932 | 0.030 |
Why?
|
Receptors, GABA | 1 | 2015 | 305 | 0.030 |
Why?
|
Heart Failure | 1 | 2017 | 11847 | 0.030 |
Why?
|
Biological Clocks | 1 | 2015 | 316 | 0.030 |
Why?
|
Rats, Wistar | 1 | 2016 | 1850 | 0.030 |
Why?
|
Comorbidity | 3 | 2017 | 10551 | 0.030 |
Why?
|
Hematologic Neoplasms | 1 | 2004 | 1895 | 0.030 |
Why?
|
Optic Nerve | 1 | 2016 | 567 | 0.030 |
Why?
|
Methylation | 1 | 2015 | 1082 | 0.030 |
Why?
|
Diagnosis | 1 | 2013 | 157 | 0.030 |
Why?
|
Abdomen | 1 | 2018 | 1130 | 0.030 |
Why?
|
Trinucleotide Repeats | 1 | 2013 | 257 | 0.020 |
Why?
|
Empathy | 1 | 2016 | 473 | 0.020 |
Why?
|
Receptors, Progesterone | 1 | 2017 | 1130 | 0.020 |
Why?
|
Chronic Disease | 3 | 2015 | 9287 | 0.020 |
Why?
|
Feasibility Studies | 2 | 2016 | 5201 | 0.020 |
Why?
|
Constriction, Pathologic | 1 | 2015 | 1098 | 0.020 |
Why?
|
Infant | 4 | 2020 | 36060 | 0.020 |
Why?
|
Longevity | 1 | 2019 | 1050 | 0.020 |
Why?
|
Germ-Line Mutation | 1 | 2020 | 1841 | 0.020 |
Why?
|
Models, Statistical | 3 | 2016 | 5075 | 0.020 |
Why?
|
Freezing Reaction, Cataleptic | 1 | 2011 | 41 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 2004 | 4166 | 0.020 |
Why?
|
Alleles | 2 | 2014 | 6898 | 0.020 |
Why?
|
Pacemaker, Artificial | 1 | 2017 | 815 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2017 | 2852 | 0.020 |
Why?
|
Receptor, erbB-2 | 2 | 2017 | 2554 | 0.020 |
Why?
|
Echo-Planar Imaging | 2 | 2006 | 657 | 0.020 |
Why?
|
Electroretinography | 1 | 2013 | 517 | 0.020 |
Why?
|
Spin Labels | 1 | 2012 | 336 | 0.020 |
Why?
|
Memory, Long-Term | 1 | 2011 | 57 | 0.020 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 4 | 2004 | 11712 | 0.020 |
Why?
|
Feedback, Psychological | 1 | 2011 | 95 | 0.020 |
Why?
|
Bayes Theorem | 1 | 1999 | 2326 | 0.020 |
Why?
|
C-Reactive Protein | 1 | 2022 | 3839 | 0.020 |
Why?
|
Analgesics, Non-Narcotic | 1 | 2013 | 370 | 0.020 |
Why?
|
Remission Induction | 1 | 2016 | 2392 | 0.020 |
Why?
|
Brain Waves | 1 | 2014 | 401 | 0.020 |
Why?
|
Nonlinear Dynamics | 1 | 2012 | 494 | 0.020 |
Why?
|
Atrophy | 2 | 2006 | 1627 | 0.020 |
Why?
|
Strabismus | 1 | 2014 | 317 | 0.020 |
Why?
|
Child Development Disorders, Pervasive | 1 | 2014 | 599 | 0.020 |
Why?
|
Acetaminophen | 1 | 2013 | 553 | 0.020 |
Why?
|
Critical Care | 1 | 2022 | 2699 | 0.020 |
Why?
|
Substantia Nigra | 1 | 2011 | 350 | 0.020 |
Why?
|
Pentetic Acid | 1 | 2009 | 209 | 0.020 |
Why?
|
Bone and Bones | 1 | 2019 | 2560 | 0.020 |
Why?
|
Bacteria | 1 | 2019 | 2199 | 0.020 |
Why?
|
Receptors, Estrogen | 1 | 2017 | 2210 | 0.020 |
Why?
|
Hemorrhage | 1 | 2021 | 3600 | 0.020 |
Why?
|
Hand Strength | 1 | 2011 | 452 | 0.020 |
Why?
|
Illusions | 1 | 2008 | 60 | 0.020 |
Why?
|
Fibrosis | 1 | 2015 | 2042 | 0.020 |
Why?
|
Family Health | 1 | 2013 | 1257 | 0.020 |
Why?
|
Neuroradiography | 1 | 2008 | 71 | 0.020 |
Why?
|
Critical Illness | 1 | 2021 | 2709 | 0.020 |
Why?
|
Rats | 2 | 2016 | 23711 | 0.020 |
Why?
|
Curriculum | 1 | 2021 | 3718 | 0.020 |
Why?
|
Afferent Pathways | 1 | 2009 | 299 | 0.020 |
Why?
|
Venous Thromboembolism | 1 | 2021 | 1864 | 0.020 |
Why?
|
Defibrillators, Implantable | 1 | 2017 | 1499 | 0.020 |
Why?
|
Sus scrofa | 1 | 2009 | 433 | 0.020 |
Why?
|
Brain Death | 1 | 2011 | 356 | 0.020 |
Why?
|
Extracellular Space | 1 | 2009 | 564 | 0.020 |
Why?
|
Databases, Factual | 1 | 2022 | 8035 | 0.020 |
Why?
|
Extrapyramidal Tracts | 1 | 2006 | 17 | 0.020 |
Why?
|
Touch | 1 | 2009 | 312 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2016 | 6216 | 0.020 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2014 | 1489 | 0.020 |
Why?
|
Cerebral Arteries | 1 | 2009 | 493 | 0.020 |
Why?
|
Pregnancy | 2 | 2020 | 29749 | 0.020 |
Why?
|
Infant, Newborn | 1 | 2006 | 26181 | 0.020 |
Why?
|
Protein Kinase Inhibitors | 1 | 2022 | 5643 | 0.020 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2010 | 1067 | 0.020 |
Why?
|
Sex Distribution | 1 | 2011 | 2295 | 0.020 |
Why?
|
Hypothermia, Induced | 1 | 2011 | 758 | 0.020 |
Why?
|
Postmortem Changes | 1 | 2005 | 119 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2016 | 6828 | 0.020 |
Why?
|
Internal Capsule | 1 | 2006 | 138 | 0.020 |
Why?
|
Parahippocampal Gyrus | 1 | 2006 | 115 | 0.020 |
Why?
|
Actigraphy | 1 | 2009 | 518 | 0.020 |
Why?
|
Catheterization | 1 | 2010 | 1432 | 0.020 |
Why?
|
Aspartic Acid | 1 | 2007 | 576 | 0.020 |
Why?
|
Obsessive-Compulsive Disorder | 1 | 2014 | 1489 | 0.020 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2015 | 15789 | 0.020 |
Why?
|
Age Distribution | 1 | 2011 | 2893 | 0.020 |
Why?
|
Phosphorylation | 1 | 2016 | 8313 | 0.020 |
Why?
|
Postoperative Complications | 2 | 2017 | 15697 | 0.020 |
Why?
|
Neural Inhibition | 1 | 2009 | 589 | 0.020 |
Why?
|
Interleukin-6 | 1 | 2015 | 3215 | 0.020 |
Why?
|
Pons | 1 | 2006 | 239 | 0.010 |
Why?
|
Neoplasms | 1 | 2013 | 22072 | 0.010 |
Why?
|
Basilar Artery | 1 | 2005 | 205 | 0.010 |
Why?
|
Chemotherapy, Adjuvant | 2 | 2003 | 3529 | 0.010 |
Why?
|
Monitoring, Immunologic | 1 | 2004 | 98 | 0.010 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 1 | 2011 | 1988 | 0.010 |
Why?
|
Low Back Pain | 1 | 2012 | 979 | 0.010 |
Why?
|
Sensory Receptor Cells | 1 | 2009 | 509 | 0.010 |
Why?
|
Middle Cerebral Artery | 1 | 2005 | 276 | 0.010 |
Why?
|
Happiness | 1 | 2005 | 170 | 0.010 |
Why?
|
Electric Stimulation | 1 | 2009 | 1735 | 0.010 |
Why?
|
Phosphorous Acids | 1 | 2003 | 4 | 0.010 |
Why?
|
Skinfold Thickness | 1 | 2003 | 158 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 2014 | 4291 | 0.010 |
Why?
|
Forearm | 1 | 2006 | 429 | 0.010 |
Why?
|
Gravitation | 1 | 2003 | 82 | 0.010 |
Why?
|
Electrochemistry | 1 | 2003 | 143 | 0.010 |
Why?
|
Coronary Circulation | 1 | 2009 | 1577 | 0.010 |
Why?
|
Histocompatibility Testing | 1 | 2004 | 717 | 0.010 |
Why?
|
Fixation, Ocular | 1 | 2004 | 240 | 0.010 |
Why?
|
Receptors, CCR5 | 1 | 2005 | 488 | 0.010 |
Why?
|
Signal Transduction | 2 | 2017 | 23376 | 0.010 |
Why?
|
Pyrimidines | 1 | 2015 | 3016 | 0.010 |
Why?
|
Lactic Acid | 1 | 2007 | 1134 | 0.010 |
Why?
|
Survival | 1 | 2002 | 161 | 0.010 |
Why?
|
Lung | 1 | 2021 | 9994 | 0.010 |
Why?
|
Posture | 1 | 2006 | 953 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2019 | 4775 | 0.010 |
Why?
|
Necrosis | 1 | 2006 | 1612 | 0.010 |
Why?
|
In Situ Hybridization | 1 | 2005 | 1900 | 0.010 |
Why?
|
Liver | 1 | 2017 | 7509 | 0.010 |
Why?
|
Down-Regulation | 1 | 2009 | 2913 | 0.010 |
Why?
|
Cell Count | 1 | 2005 | 1835 | 0.010 |
Why?
|
Magnetic Resonance Angiography | 1 | 2008 | 1431 | 0.010 |
Why?
|
Etoposide | 1 | 2002 | 630 | 0.010 |
Why?
|
Mitochondria | 1 | 2014 | 3600 | 0.010 |
Why?
|
Carboplatin | 1 | 2004 | 788 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2014 | 12159 | 0.010 |
Why?
|
Hematoma | 1 | 2005 | 769 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2011 | 8158 | 0.010 |
Why?
|
Arm | 1 | 2003 | 583 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2016 | 10446 | 0.010 |
Why?
|
Receptors, CXCR4 | 1 | 2005 | 728 | 0.010 |
Why?
|
Blood Pressure | 1 | 2015 | 8525 | 0.010 |
Why?
|
Echocardiography, Transesophageal | 1 | 2005 | 1108 | 0.010 |
Why?
|
Animals, Newborn | 1 | 2005 | 2672 | 0.010 |
Why?
|
Chromatography, Liquid | 1 | 2003 | 987 | 0.010 |
Why?
|
Body Weight | 1 | 2009 | 4611 | 0.010 |
Why?
|
Syndrome | 1 | 2005 | 3280 | 0.010 |
Why?
|
Mice | 2 | 2016 | 81208 | 0.010 |
Why?
|
Anthropometry | 1 | 2003 | 1348 | 0.010 |
Why?
|
Muscles | 1 | 2003 | 1581 | 0.010 |
Why?
|
Postoperative Period | 1 | 2003 | 1818 | 0.010 |
Why?
|
Child Development | 1 | 2010 | 2285 | 0.010 |
Why?
|
Internet | 1 | 2009 | 3078 | 0.010 |
Why?
|
Gestational Age | 1 | 2006 | 3565 | 0.010 |
Why?
|
Recurrence | 1 | 2009 | 8482 | 0.010 |
Why?
|
Emergency Medical Services | 1 | 2008 | 1925 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2015 | 22023 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2005 | 4899 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2005 | 10344 | 0.010 |
Why?
|
Paclitaxel | 1 | 2004 | 1736 | 0.010 |
Why?
|
Cisplatin | 1 | 2002 | 1644 | 0.010 |
Why?
|
Risk Assessment | 2 | 2009 | 24123 | 0.010 |
Why?
|
Inflammation | 1 | 2015 | 10756 | 0.010 |
Why?
|
Software | 1 | 2009 | 4419 | 0.010 |
Why?
|
Viral Load | 1 | 2005 | 3322 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2005 | 2696 | 0.010 |
Why?
|
Transcription Factors | 1 | 2014 | 12103 | 0.010 |
Why?
|
Adaptation, Psychological | 1 | 2005 | 2628 | 0.010 |
Why?
|
Patient Compliance | 1 | 2004 | 2688 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2009 | 12965 | 0.010 |
Why?
|
Graft Survival | 1 | 2004 | 3794 | 0.010 |
Why?
|
Logistic Models | 1 | 2008 | 13314 | 0.010 |
Why?
|
Epilepsy | 1 | 2009 | 3267 | 0.010 |
Why?
|
Lymph Nodes | 1 | 2004 | 3486 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2005 | 10827 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2003 | 8552 | 0.010 |
Why?
|
Survival Analysis | 1 | 2004 | 10182 | 0.010 |
Why?
|
Antipsychotic Agents | 1 | 2004 | 3061 | 0.010 |
Why?
|
Sex Factors | 1 | 2002 | 10547 | 0.000 |
Why?
|
Diabetes Mellitus | 1 | 2005 | 5889 | 0.000 |
Why?
|
Antibodies, Monoclonal | 1 | 2004 | 9185 | 0.000 |
Why?
|
Hypertension | 1 | 2005 | 8594 | 0.000 |
Why?
|
Myocardial Infarction | 1 | 2006 | 11891 | 0.000 |
Why?
|